Is VGHF11 worth it? Analysis of Valora Hedge Fund FII
Recommendation: HOLD · Rating 5,9/10
Analysis and recommendation
VGHF11 is a multi-strategy hybrid REIT from Valora with R$ 1.40 Bn in net assets spread across 137 assets (CRI 29.5% + REIT 57.4% + SPE 14.8% + FIDC 1.0% + Equities 0.7%). The P/BV of 0.68 offers a 32% discount and the 12-month DY of 14.6% is above the segment median, but the investor needs to understand four central risks: (i) ~14.6% of net assets allocated to REITs of the Valora family itself (VGRI11, Valora CRI Pré, Valora CRI Infra, Valora FOF, VGIR11, VGIP11) — exposure INCREASED in Apr/26 even with the reduction of VGIR11; potential conflict of interest mitigated by governance, but structural; (ii) Selina CRIs (~1.8% of net assets) marked to zero for 23 months with no recovery prospect; (iii) NAV per unit in STRUCTURAL DECLINE — fell from R$ 8.75 (Jan/26) to R$ 8.53 (Apr/26), -2.5% in 4 months, pressured by the widening of the NTN-B (MtM -R$ 19.5 M in Apr/26); (iv) Unitholders fleeing: -5,272 unitholders in 1 month (Mar→Apr/26). DPS of R$ 0.07 held for the 7th month but the accounting result is NEGATIVE (-R$ 8.3 M in Apr/26). The 6th offering (R$ 1.2 Bn announced) remains a relevant catalyst.
Investment thesis
VGHF11 is a consolidated multi-strategy REIT — 5 years of operation, R$ 1.40 Bn in net assets, 137 assets, extreme risk dispersion. It trades at P/BV 0.68 and offers a DY of 14.6% on the market price, above the hybrid segment median (~12.5%). The long-term thesis is simple: buy a broadly diversified portfolio at a 32% discount to book value with tax-exempt monthly income. The threads to watch are: (1) ~14.6% of net assets in REITs of the Valora family itself — not prohibited by the regulation, but structural and opportunistic for the house (ROSE in Apr/26 from 12% to 14.6%); (2) DPS gradually declining over the last 24 months (from R$ 0.10 to R$ 0.07) — stable for 7 months; (3) NAV per unit declining continuously for 4 months (R$ 8.75 → R$ 8.53), pressured by NTN-B; and (4) 6th offering of R$ 1.2 Bn at R$ 9.19 with the market price at R$ 5.77 — risk of offering failure or relevant dilution.
Who it's for
Monthly-income investors who accept a stable DPS of ~R$ 0.07/unit with a DY of 14.6% on the market price
A moderate profile seeking broad sector diversification via a single ticker
Those who value a sustained discount to book value (P/BV 0.68 for 12+ months)
Investors who accept a declared potential conflict of in-house REITs in exchange for experienced paper-fund management
Who it's not for
Those seeking DPS growth — the fund has been on a plateau for 7 months with no clear catalysts for an increase
Investors who do not accept exposure to REITs of the same management house
Those who need a crystal-clear thesis and an identifiable asset — 137 assets is excessive dispersion for selective profiles
Conservative investors who avoid problematic credit (Selina marked to zero for 23 months)
Those entering before the 6th offering without understanding the dilution risk if the offering comes out at a discount
Points of attention and risks
~14.6% concentration in REITs of the Valora family itself (rose)
VGHF11 holds R$ 71.4 M (Valora CRI Pré, 5.08% of net assets), R$ 66.9 M (Valora FOF, 4.76% of net assets), R$ 32.5 M (VGRI11/Valora Renda, 2.32% of net assets), R$ 24.5 M (Valora CRI Infra, 1.74% of net assets), R$ 8.1 M (VGIP11/Valora CRI Índice, 0.58%) and R$ 1.6 M (VGIR11/Valora CRI CDI, 0.11% — reduced from R$ 9.7 M in Apr/26). Total ~R$ 204.9 M ≈ 14.6% of net assets — rose from ~12% (Feb/26) DESPITE the reduction of VGIR11 by R$ 6.27 M. The other family positions gained weight in the portfolio. Potential conflict of interest — the manager invests in funds it manages itself, capturing a fee at both ends. Mitigated by formal governance but structural. Aggravating factor identified by the community (TiagoPS, 05/06/2026): VGHF11 holds the SUBORDINATED unit (paid last) of the Valora CRI Pré Subordinada fund (5.12% of net assets). In 2026, that product paid income only to the senior unit — the subordinated unit (VGHF11) received nothing. The anchoring was done in Dec/2025. The same occurs with BGRJ11 (3.79% of net assets), a structured fund linked to VGRI11 (leveraged Valora office floors), which paid R$ 0 in Mar/26 and only R$ 0.20/unit in Apr/26.
Selina CRIs marked to zero for ~23 months
4 Selina CRIs (128S, 162S, 163S, 164S) totaling ~1.8% of the original net assets are marked at R$ 0 since Jun/2024, following the default of Selina (a hostel-startup chain). No recent communication about judicial reorganization, enforcement of guarantees or repayment. A partial recovery would generate a positive revaluation, but the Manager neither quantifies it nor gives a deadline.
DPS stable at R$ 0.07/unit for 7 months (all-time low)
Since Nov/2025 the fund has paid R$ 0.07/unit consecutively (7 months through May/2026), with a structural drop vs ~R$ 0.10/unit (2024) and ~R$ 0.13 (Jun/2021). Distributable result in Apr/26: R$ 11.26 M vs distribution of R$ 11.53 M (distribution slightly above what was generated, consuming the small retained balance). A reflection of the widening of the NTN-B curve (IPCA CRIs marked to market) and the sale of value REITs at a loss. Community estimate (user duvieira, 04/30/2026, based on the management report): the real recurring result would be ~R$ 0.0492/unit — about R$ 0.022/unit would come from accumulated reserves to maintain the R$ 0.07. If the reserves run out, DPS could fall to R$ 0.05-0.06.
Reverse repurchase agreements R$ 42.8 M (3.0% of net assets) — reduced implicit leverage
Sale-and-future-repurchase operations of CRIs (reverse repo) at an average cost of CDI + 0.84% p.a., totaling R$ 42.8 M to be exercised over the next 12 months — REDUCED from R$ 51.6 M (Feb/26) to R$ 42.8 M (Apr/26), a marginal improvement. Although the report classifies it as 'net cash', it represents a repurchase obligation — slight disguised leverage that pressures nominal net cash (-R$ 48.6 M vs +R$ 4.5 M gross).
Hotel exposure 0% (Selina marked to zero) — heavy residential concentration
CRI portfolio: high concentration in Residential (developers Helbor, Tecnisa, Manhattan, Realiza, You). Risk peak if the real-estate cycle turns.
6th offering of R$ 1.2 Bn announced — dilution risk
Offering with an initial volume of 130.576 M units at R$ 9.19 (above the NAV of R$ 8.53 and well above the market price of R$ 5.77). For the offering to work at the book-value price, the manager will need to offer a discount or special conditions. If it comes out at the current market price, it dilutes existing unitholders.
B3 issued a notice about atypical fluctuation — the unit fell ~19% in 2 weeks and the administrator says it knows nothing
On 05/11/2026 B3 sent Banco Daycoval (the administrator) Notice 113/2026-SLE requesting clarification about the drop in the units from R$ 6.94 (04/27) to R$ 5.63 (05/11) — a ~19% decline in 9 trading sessions, with a peak drop of -7.40% on 05/11 itself and daily volume jumping from ~10,000 to ~19,000 trades. Daycoval's response on 05/12/2026: it 'is not aware of the existence of any specific fact (...) that would justify the fluctuations' and states it received no information from the Manager (Valora) about an undisclosed material fact. Practical implication: the unit's discount widened again (P/BV ~0.68 → a pressured pre-offering level), which makes pricing the 6th offering at R$ 9.19 even more challenging. See article: artigos/vghf11-b3-oscilacao-atipica-queda-19-pct-mai-2026.html.
NAV per unit in STRUCTURAL DECLINE — fell R$ 0.22 (-2.5%) in 4 months
NAV per unit fell from R$ 8.75 (Jan/26) → R$ 8.73 (Feb/26) → R$ 8.65 (Mar/26) → R$ 8.53 (Apr/26) — a continuous decline over 4 consecutive months. Drivers: the widening of the NTN-B curve pressuring the mark-to-market of the IPCA CRIs (MtM adjustment of -R$ 19.55 M in Apr/26 alone) + the devaluation of portfolio REITs. Accounting result NEGATIVE for the 2nd consecutive month (-R$ 8.30 M in Apr/26). If the NTN-B curve keeps widening, NAV keeps falling and DPS could be pressured to R$ 0.06.
Unitholders fleeing — loss of 5,272 unitholders in 1 month
The unitholder base fell from 383,457 (Mar/26) to 378,185 (Apr/26) — a loss of 5,272 unitholders (-1.4%) in a single month. A trend of investors leaving in the very short term, possibly in reaction to the B3 Notice (atypical fluctuation) and the NAV decline. The first clear sign of discomfort in the base — historically VGHF11 had been growing its unitholders month over month.
Is VGHF11 trustworthy?
Our current reading of VGHF11 is HOLD, with a score of 5,9/10. This score comes neither from the manager nor the administrator: it is Rico aos Poucos' editorial assessment, built from the documents the fund files with the CVM. Below is what supports it — and what argues against it.
Consolidated Valora multi-strategy (5 years, R$ 1.4 Bn net assets, 137 assets, 378k unitholders) with P/BV 0.73 and DY 14.6%. 14.6% of net assets in REITs of the Valora family itself (up from ~12%) with a subordinated unit that received no income. Selina CRIs marked to zero for 23 months. DPS R$ 0.07 stable (vs ~R$ 0.10 in 2024). Falls into the HOLD range due to governance.
Is VGHF11 safe?
Safety in a REIT is not yes or no — it is how much risk you accept. VGHF11 has a medio risk profile. What that means in practice:
Component
Level
Concentration
1,5
Price volatility
3,2
Dividend volatility
3,5
Liquidity
1,5
Underlying asset risk
3,5
Financial/leverage risk
3,0
Risks that don't show up in VGHF11's fact sheet
Conflict of interest with Valora house funds (rose to 14.6%)
14.6% of net assets in funds managed by Valora itself generates a double fee layer (VGHF fee + the invested funds' fees). Although declared and legitimate, it is structural — the manager has an incentive to keep the position even if there is a more attractive market alternative. In Apr/26 the exposure rose even with the reduction of VGIR11.
Reverse repurchase agreements R$ 42.8 M as disguised leverage
Sales with a future repurchase commitment of CRIs appear as negative cash in the report. Functionally, it works as leverage — it raises effective exposure without appearing as debt.
Selina pending with no clear recovery communication
1.8% of net assets marked to zero for 23 months with no substantive updates. Upside risk (partial recovery) but also downside (permanent).
Concentration in mid-sized developers (Helbor, Tecnisa, Manhattan, Realiza, You)
Several CRIs backed by SPEs of mid-sized developers. In an unfavorable real-estate cycle, all are at risk simultaneously — diversification by number of assets does not protect against sector correlation.
Asymmetric performance fee above IMA-B 5
The manager receives 20% of whatever exceeds IPCA + the previous half-year's IMA-B 5 yield, with a floor of IPCA + 3% p.a. In a high-IMA-B-5 scenario (8-9% p.a.), the manager needs to deliver a lot to trigger performance — the right incentive. In a low-IMA-B-5 scenario (4-5%), the trigger becomes easier.
NAV declining continuously for 4 months + unitholders leaving
NAV fell R$ 0.22 (-2.5%) in 4 months, with persistent negative MtM. The unitholder base lost 5,272 in 1 month (Mar→Apr/26). A combination that could pressure the unit to seek a new, lower equilibrium.
Scenarios for VGHF11
Scenario
Description
Selic falls to 11% and the unit closes at P/BV 0.82
Partial recovery of the Selina CRIs (~50%)
The 6th offering comes out successfully and DPS rises to R$ 0.08-0.09
The 6th offering fails or comes out at a discount, diluting unitholders
DPS falls to R$ 0.06 with a new widening of the NTN-B curve
Acceleration of the unitholder flight with NAV falling
Conclusion
The VGHF11 is a consolidated snapshot of a Brazilian hybrid REIT: 5 years of operation, R$ 1.40 Bn in net assets, 137 assets spread across 5 classes (CRI, REIT, SPE, FIDC, real-estate equities) and 378 thousand unitholders. The Valora house has built a robust and liquid vehicle, but decisively it is not a simple fund: the thesis requires the investor to understand four structural threads — a DPS on a descending plateau, a NAV declining continuously for 4 months, growing exposure to funds of its own family (14.6%) and the scar of the Selina default.
The great virtue is extreme diversification with very good liquidity in a single position — a profile that is hard to replicate in other tickers. P/BV 0.68 offers a 32% margin to book value and a DY of 14.6% is competitive. The great fragility is the DPS stagnant at R$ 0.07 (all-time low) with no clear catalysts to rise, combined with the growing dependence on the Valora house itself (~14.6% of net assets) and the persistent negative MtM that has been eroding the NAV.
The base-case scenario for the next 12 months is sideways: DPS of R$ 0.07 maintained, the unit oscillating R$ 5.30-6.50, total return of ~14%. What could change this course: (1) success of the 6th offering and recycling at a high cap rate; (2) a fall in the Selic rate as per Focus; (3) partial Selina recovery. Symmetric risk: the offering fails, the NTN-B widens further, a new default in a Residential CRI, the flight of unitholders accelerates.
Frequently asked questions
Is VGHF11 good? Is it worth investing?
Current recommendation: HOLD. Rating 5,9/10. VGHF11 is a multi-strategy hybrid REIT from Valora with R$ 1.40 Bn in net assets spread across 137 assets (CRI 29.5% + REIT 57.4% + SPE 14.8% + FIDC 1.0% + Equities 0.7%). The P/BV of 0.68 offers a 32% discount and the 12-month DY of 14.6% is above the segment median, but the…
VGHF11: buy or sell?
Our current read on VGHF11 is “HOLD”. Rating 5,9/10. Assess it against your risk profile and the points of attention listed above.
What are VGHF11's risks?
The main points of attention for Valora Hedge Fund FII include: ~14.6% concentration in REITs of the Valora family itself (rose); Selina CRIs marked to zero for ~23 months; DPS stable at R$ 0.07/unit for 7 months (all-time low); Reverse repurchase agreements R$ 42.8 M (3.0% of net assets) — reduced implicit leverage.
Who is VGHF11 suitable for?
VGHF11 is suitable for: Monthly-income investors who accept a stable DPS of ~R$ 0.07/unit with a DY of 14.6% on the market price A moderate profile seeking broad sector diversification via a single ticker Those who value a sustained discount to book value (P/BV 0.68 for 12+ months)